<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="C0033975,C0459435" disease_type="Mental or Behavioral Dysfunction;Finding" abbrv="">Psychotic</z:e> patients are at increased risk of <z:hpo ids='HP_0001907'>thromboembolism</z:hpo> that cannot be ascribed to physical restraint or medication </plain></SENT>
<SENT sid="1" pm="."><plain>Patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0100753'>schizophrenia</z:hpo> or long-term <z:e sem="disease" ids="C0011581" disease_type="Mental or Behavioral Dysfunction" abbrv="">depressive illness</z:e> do not display ischemic brain injuries on magnetic resonance imaging, as expected in patients with thrombotic tendency, but <z:mpath ids='MPATH_127'>atrophy</z:mpath> of specific brain regions, which indicates abnormal neuronal plasticity </plain></SENT>
<SENT sid="2" pm="."><plain>HYPOTHESES: We postulate that a relationship between <z:hpo ids='HP_0000709'>psychosis</z:hpo> pathophysiology and thrombotic tendency may comprise proteins that participate not only in the anticoagulation-fibrinolysis mechanism, but also in neuronal plasticity </plain></SENT>
<SENT sid="3" pm="."><plain>CASE DESCRIPTION: Five <z:e sem="disease" ids="C0033975,C0459435" disease_type="Mental or Behavioral Dysfunction;Finding" abbrv="">psychotic</z:e> patients with thrombotic episodes on <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:chebi fb="8" ids="10033">warfarin</z:chebi> therapy attained remission of <z:e sem="disease" ids="C0033975,C0459435" disease_type="Mental or Behavioral Dysfunction;Finding" abbrv="">psychotic</z:e> symptoms and are free of psychotropic medication from 2 to 11years </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients have at least one <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> related to inhibition of plasminogen activators, including prothrombin G20.210A polymorphism, <z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">hyperhomocysteinemia</z:e>, <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> syndrome and <z:hpo ids='HP_0005543'>protein C deficiency</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>DISCUSSION: Plasminogen activators participate in blood clot dissolution and tissue repair, such as remodeling of hippocampus after stress, trauma, <z:hpo ids='HP_0001297'>stroke</z:hpo> or <z:hpo ids='HP_0001250'>seizures</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>A significant prevalence of both <z:hpo ids='HP_0001907'>thromboembolism</z:hpo> and <z:e sem="disease" ids="C0033975,C0459435" disease_type="Mental or Behavioral Dysfunction;Finding" abbrv="">psychotic</z:e> events can be seen in circumstances characterized by physiological or pathological inhibition of plasminogen activators, such as puerperium, confinement, <z:hpo ids='HP_0000147'>polycystic ovary</z:hpo> syndrome, <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> syndrome and <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C1290884" disease_type="Disease or Syndrome" abbrv="">inflammatory disorders</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: Our findings suggest that normalization of plasminogen activator levels in the brain may induce long-term remission of <z:e sem="disease" ids="C0033975,C0459435" disease_type="Mental or Behavioral Dysfunction;Finding" abbrv="">psychotic</z:e> symptoms </plain></SENT>
<SENT sid="8" pm="."><plain>Randomized controlled studies may help clarify the role of anticoagulation in the treatment of <z:hpo ids='HP_0000709'>psychosis</z:hpo> </plain></SENT>
</text></document>